125 related articles for article (PubMed ID: 37633192)
1. Inhibitors of cannabinoid receptor 1 suppress the cellular entry of Lujo virus.
Kimura M; Matsuoka R; Taniguchi S; Maruyama J; Paessler S; Oka S; Yamashita A; Fukuhara T; Matsuura Y; Tani H
Virology; 2023 Oct; 587():109867. PubMed ID: 37633192
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanisms Underlying the Cellular Entry and Host Range Restriction of Lujo Virus.
Saito T; Hattori T; Okuya K; Manzoor R; Miyamoto H; Kajihara M; Takada A
mBio; 2021 Feb; 13(1):e0306021. PubMed ID: 35164564
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus.
Tani H; Iha K; Shimojima M; Fukushi S; Taniguchi S; Yoshikawa T; Kawaoka Y; Nakasone N; Ninomiya H; Saijo M; Morikawa S
J Virol; 2014 Jul; 88(13):7317-30. PubMed ID: 24741091
[TBL] [Abstract][Full Text] [Related]
4. Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform.
Welch SR; Spengler JR; Genzer SC; Chatterjee P; Flint M; Bergeron É; Montgomery JM; Nichol ST; Albariño CG; Spiropoulou CF
Viruses; 2021 Jun; 13(7):. PubMed ID: 34203149
[TBL] [Abstract][Full Text] [Related]
5. Screening and Identification of Lujo Virus Entry Inhibitors From an Food and Drug Administration-Approved Drugs Library.
Cao J; Dong S; Liu Y; Zhou M; Guo J; Jia X; Zhang Y; Hou Y; Tian M; Xiao G; Wang W
Front Microbiol; 2021; 12():793519. PubMed ID: 34925303
[TBL] [Abstract][Full Text] [Related]
6. NRP2 and CD63 Are Host Factors for Lujo Virus Cell Entry.
Raaben M; Jae LT; Herbert AS; Kuehne AI; Stubbs SH; Chou YY; Blomen VA; Kirchhausen T; Dye JM; Brummelkamp TR; Whelan SP
Cell Host Microbe; 2017 Nov; 22(5):688-696.e5. PubMed ID: 29120745
[TBL] [Abstract][Full Text] [Related]
7. Delayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaques.
Rasmussen AL; Tchitchek N; Safronetz D; Carter VS; Williams CM; Haddock E; Korth MJ; Feldmann H; Katze MG
J Virol; 2015 Mar; 89(5):2543-52. PubMed ID: 25520505
[TBL] [Abstract][Full Text] [Related]
8. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for receptor recognition by Lujo virus.
Cohen-Dvashi H; Kilimnik I; Diskin R
Nat Microbiol; 2018 Oct; 3(10):1153-1160. PubMed ID: 30150732
[TBL] [Abstract][Full Text] [Related]
10. Biological Characterization of Conserved Residues within the Cytoplasmic Tail of the Pichinde Arenaviral Glycoprotein Subunit 2 (GP2).
Shao J; Huang Q; Liu X; Di D; Dileepan M; Brisse M; Ly H; Liang Y
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462569
[TBL] [Abstract][Full Text] [Related]
11. [Lujo hemorrhagic fever].
Sizikova TE; Lebedev VN; Syromyatnikova SI; Borisevich SV
Vopr Virusol; 2017; 62(4):149-153. PubMed ID: 29733163
[TBL] [Abstract][Full Text] [Related]
12. CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.
Takenaga T; Zhang Z; Muramoto Y; Fehling SK; Hirabayashi A; Takamatsu Y; Kajikawa J; Miyamoto S; Nakano M; Urata S; Groseth A; Strecker T; Noda T
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578344
[TBL] [Abstract][Full Text] [Related]
13. Severe hemorrhagic fever in strain 13/N guinea pigs infected with Lujo virus.
Bird BH; Dodd KA; Erickson BR; Albariño CG; Chakrabarti AK; McMullan LK; Bergeron E; Ströeher U; Cannon D; Martin B; Coleman-McCray JD; Nichol ST; Spiropoulou CF
PLoS Negl Trop Dis; 2012; 6(8):e1801. PubMed ID: 22953019
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of arenavirus infection by a novel fusion inhibitor.
Gowen BB; Naik S; Westover JB; Brown ER; Gantla VR; Fetsko A; Dagley AL; Blotter DJ; Anderson N; McCormack K; Henkel G
Antiviral Res; 2021 Sep; 193():105125. PubMed ID: 34197863
[TBL] [Abstract][Full Text] [Related]
15. Breaking the Barrier: Host Cell Invasion by Lujo Virus.
Kunz S; de la Torre JC
Cell Host Microbe; 2017 Nov; 22(5):583-585. PubMed ID: 29120740
[TBL] [Abstract][Full Text] [Related]
16. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.
Wang P; Liu Y; Zhang G; Wang S; Guo J; Cao J; Jia X; Zhang L; Xiao G; Wang W
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899092
[No Abstract] [Full Text] [Related]
17. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa.
Briese T; Paweska JT; McMullan LK; Hutchison SK; Street C; Palacios G; Khristova ML; Weyer J; Swanepoel R; Egholm M; Nichol ST; Lipkin WI
PLoS Pathog; 2009 May; 5(5):e1000455. PubMed ID: 19478873
[TBL] [Abstract][Full Text] [Related]
18. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
Isono M; Furuyama W; Kuroda M; Kondoh T; Igarashi M; Kajihara M; Yoshida R; Manzoor R; Okuya K; Miyamoto H; Feldmann H; Marzi A; Sakaitani M; Nanbo A; Takada A
Antiviral Res; 2020 Nov; 183():104932. PubMed ID: 32946918
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Glycoprotein Stable Signal Peptide in Mediating Pichinde Virus Replication and Virulence.
Shao J; Liu X; Ly H; Liang Y
J Virol; 2016 Nov; 90(22):10390-10397. PubMed ID: 27630230
[TBL] [Abstract][Full Text] [Related]
20. A specific interaction of small molecule entry inhibitors with the envelope glycoprotein complex of the Junín hemorrhagic fever arenavirus.
Thomas CJ; Casquilho-Gray HE; York J; DeCamp DL; Dai D; Petrilli EB; Boger DL; Slayden RA; Amberg SM; Sprang SR; Nunberg JH
J Biol Chem; 2011 Feb; 286(8):6192-200. PubMed ID: 21159779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
